Publications by authors named "M Weinfeld"

Uncontrolled degradation and collapse of stalled replication forks (RFs) are primary sources of genomic instability, yet the molecular mechanisms for protecting forks from degradation/collapse remain to be fully elaborated. Here, we show that polynucleotide kinase-phosphatase (PNKP) localizes at stalled forks and protects stalled forks from excessive degradation. The loss of PNKP results in nucleolytic degradation of nascent DNA at stalled RFs.

View Article and Find Full Text PDF

Background: DNA repair plays a major role in maintaining genomic stability, thus limiting the transformation of normal cells into cancer cells. However, in cancer patients treated with DNA-targeting drugs, DNA repair can decrease efficacy by removing the damage generated by such molecules that is needed to induce pharmacological activity. Inhibiting DNA repair thus represents an interesting approach to potentiating the activity of chemotherapy in this setting.

View Article and Find Full Text PDF
Article Synopsis
  • Okazaki fragment maturation (OFM) is essential for maintaining genome integrity, and its disruption can lead to DNA damage associated with diseases like cancer and neurodegeneration.
  • Recent research has identified the role of polynucleotide kinase-phosphatase (PNKP) alongside LIG3-XRCC1 in an alternative pathway for OFM, demonstrating its significance in DNA replication.
  • PNKP is shown to be involved in replication fork dynamics and is phosphorylated by cyclin-dependent kinases (CDK1/2), which is crucial for its function in DNA replication and maintaining genome stability.
View Article and Find Full Text PDF

Breast cancer (BC) is a leading global concern for women, with 30% being HER2-positive cases linked to poorer outcomes. Targeted therapies like trastuzumab deruxtecan (T-DXd), trastuzumab, pertuzumab, and T-DM1 have revolutionized HER2-positive metastatic breast cancer (MBC) treatment. Although these therapies have improved MBC management and patient outcomes, resistance can develop, reducing effectiveness.

View Article and Find Full Text PDF

DNA glycosylase dysregulation is implicated in carcinogenesis and therapeutic resistance of cancers. Thus, various DNA-based detection platforms have been developed by leveraging the base excision activity of DNA glycosylases. However, the efficacy of DNA-based methods is hampered due to nonspecific degradation by nucleases commonly present in cancer cells and during preparations of cell lysates.

View Article and Find Full Text PDF